Gilead Sciences Inc. (GILD)

Index:

Nasdaq 100

$ 150.93
   
  • Change Today:
    $1.24
  • 52 Week High: $155.80
  • 52 Week Low: $110.56
  • Currency: US Dollars
  • Shares Issued: 1,241.00m
  • Volume: 5,284,284
  • Market Cap: $187,304m
  • RiskGrade: 120
  • Beta: 0.01

Latest ShareCast News

Gilead Sciences to buy German biotech group Tubulis for up to $5bn

By Michele Maatouk

Date: Tuesday 07 Apr 2026

(Sharecast News) - California-based Gilead Sciences said on Tuesday that it has agreed to buy German clinical stage biotechnology group Tubulis for up to $5bn.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GILD Market Data

Currency US Dollars
Share Price $ 150.93
Change Today $ 1.24
% Change 0.83 %
52 Week High $155.80
52 Week Low $110.56
Volume 5,284,284
Shares Issued 1,241.00m
Market Cap $187,304m
Beta 0.01
RiskGrade 120

What The Brokers Say

Strong Buy 8
Buy 15
Neutral 5
Sell 1
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 25-Sep-2026

Time Volume / Share Price
15:59 334 @ $150.91
15:59 100 @ $150.91
15:59 100 @ $150.91
15:59 100 @ $150.91
15:59 2,475 @ $150.90

Top of Page